AI
Tuesday, March 19, 2019 2:42:33 PM
I'm simple minded, so I'd protest reading that another drug/research is an exclusive one. They know better (I hope), or they don't deal with CytRx things at all!
You did well yesterday to buy, because something's started, I don't think PPS'd fall below $.70 in our era!
I listened NH webinar about theire network and digitalisation of cancer treatment. The idea's perfect, PSS's trying collect all information to his server! The system's good for everybody, cheap, fast, opening wide database and treatment experiment to use. My queston that big competitors will allow to develope that network or block it and make cancel it to theire partner hospitals, and cancer centers.
Anyway, NK and NH are promising as much Patrick (not saint) is correct! I didn't buy any of these stocks (yet). We'll see after the glorious CytRx time!
Waiting for ER without big expectation, but a positive PR after!
GL
You did well yesterday to buy, because something's started, I don't think PPS'd fall below $.70 in our era!
I listened NH webinar about theire network and digitalisation of cancer treatment. The idea's perfect, PSS's trying collect all information to his server! The system's good for everybody, cheap, fast, opening wide database and treatment experiment to use. My queston that big competitors will allow to develope that network or block it and make cancel it to theire partner hospitals, and cancer centers.
Anyway, NK and NH are promising as much Patrick (not saint) is correct! I didn't buy any of these stocks (yet). We'll see after the glorious CytRx time!
Waiting for ER without big expectation, but a positive PR after!
GL
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
